CVR: 45346951
Previous names: Asprita ApS
DKK 23,793
Gross profit
Net result: DKK 18,491
ASPRITA LIMITED
CVR · view ownership and management
Name registered: Parity Pharma ApS
CVR · 09/07/2026
View the full event history
Parity Pharma ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2025. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Asprita ApS. The management consists of Simon James Dorris. The company is owned by ASPRITA LIMITED. In 2025, the company reported a gross profit of DKK 23,793 and a net result of DKK 18,491. Equity in the 2025 report amounted to DKK 58,491.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Source: annual reports filed with the Danish Business Authority.
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringParity Pharma ApS was founded on 20 January 2025.
Parity Pharma ApS is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
Parity Pharma ApS is owned by ASPRITA LIMITED.
In 2025, Parity Pharma ApS reported a gross profit of DKK 23,793.
The management of Parity Pharma ApS consists of Simon James Dorris.
Parity Pharma ApS is located at c/o Bird & Bird Advokatpartnerselskab, Kalkbrænderiløbskaj 8 st., 2100 København Ø.
Claim this page to add your logo and social links. Free to get started.
On July 9, 2026, the company changed its name from Asprita ApS to Parity Pharma ApS.
Parity Pharma ApS has published its annual report for 2025. Gross profit came to DKK 23,793, and the net result was DKK 18,491.
As of August 29, 2025, is registered as an owner of Parity Pharma ApS with an ownership share of 100%.
As of January 20, 2025, Simon James Dorris is registered as director of Parity Pharma ApS.
Parity Pharma ApS was founded on January 20, 2025.
Companies in the same industry and area
CVR 45929698
CVR 46098765
CVR 19064301
CVR 37726508
CVR 44420449
